Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease

E-ISSN： 1873-4286|15|31|3644-3655

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.31, 2009-11, pp. : 3644-3655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Towards Understanding the Structure-Function Relationship of Human Amyloid Disease

Current Drug Targets, Vol. 5, Iss. 2, 2004-01 ,pp. : 159-171

Bentham Science Publishers

Access to resources Recommend Favorite

Geniposide Regulates Insulin-Degrading Enzyme Expression to Inhibit the Cytotoxicity of A&bgr;1-42 in Cortical Neurons

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1045-1051

Bentham Science Publishers

Access to resources Recommend Favorite

Structural and Functional Characterization of Pathogenic Non- Synonymous Genetic Mutations of Human Insulin-Degrading Enzyme by In Silico Methods

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 517-532

Bentham Science Publishers

Access to resources Recommend Favorite

Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer&aposs Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting A&bgr; Accumulation

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 3, 2015-04 ,pp. : 360-369

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Corticotropin Releasing Factor (CRF) and Its Receptors: From Structure to Function in Health and Disease (Part II)

Current Molecular Pharmacology, Vol. 11, Iss. 1, 2018-01 ,pp. : 2-3

Bentham Science Publishers

Access to resources Recommend Favorite